5 days ago
MIRM
AnalystsJessica FyeJessica Fye's Stock Forecasts
AnalystsJessica Fye
Analyst Ranking
Top 4%
#190 out of 5018 analysts
Average Return
+19.47%
Win Rate
63%85 out of 135
Risk vs Reward
Poor
Good
Jessica Fye's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Rayzebio IncRYZB | +212.45% | $20.00 | $62.49 | 2023-10-09 - 2024-02-23 | Strong Buy |
Insmed IncINSM | +199.43% | $24.62 | $73.72 | 2023-11-19 - 2024-11-19 | Strong Buy |
Stemline Therapeutics IncSTML | +178.35% | $4.25 | $11.83 | 2020-03-25 - 2020-06-10 | Strong Buy |
Ascendis Pharma AASND | +134.77% | $27.90 | $65.50 | 2017-05-10 - 2018-05-11 | Strong Buy |
Insmed IncINSM | +102.73% | $71.40 | $144.75 | 2024-10-02 - 2025-09-16 | Strong Buy |
Jessica Fye Analyst Color
Get additional color on Jessica Fye's coverage of popular stocks
23 days ago
LEGN
a month ago
INSM
a month ago
ASND
a month ago
ALNY
2 months ago
ONC
2 months ago
ALNY
2 months ago
INSM
3 months ago
ALNY
5 months ago
ASND
6 months ago
ALNY
6 months ago
ASND
7 months ago
INSM
8 months ago
ASND
10 months ago
INSM
10 months ago
ITCI
a year ago
ONC
a year ago
BMRN
a year ago
ASND
a year ago
ONC
a year ago
JAZZ
a year ago
DNLI
a year ago
INSM
a year ago
MIRM
a year ago
INSM
Jessica Fye's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Mirum Pharmaceuticals IncMIRM | 4 | Strong Buy | $77.00 | +4.35% | Maintains | 5 days ago |
Alkermes PLCALKS | 7 | Hold | $35.00 | +27.78% | Maintains | 8 days ago |
Legend Biotech CorpLEGN | 3 | Strong Buy | $78.00 | +127.14% | Maintains | 23 days ago |
Ionis Pharmaceuticals IncIONS | 6 | Hold | $49.00 | -20.08% | Maintains | 23 days ago |
Incyte CorpINCY | 8 | Hold | $73.00 | -12.99% | Maintains | a month ago |
Insmed IncINSM | 9 | Strong Buy | $135.00 | -6.74% | Maintains | a month ago |
Ascendis Pharma AASND | 14 | Strong Buy | $260.00 | +31.82% | Maintains | a month ago |
Halozyme Therapeutics IncHALO | 8 | Hold | $63.00 | -16.94% | Maintains | a month ago |
Alnylam Pharmaceuticals IncALNY | 8 | Strong Buy | $475.00 | +2.98% | Maintains | a month ago |
Beone Medicines LtdONC | 7 | Strong Buy | $345.00 | +5.44% | Maintains | 2 months ago |
Vertex Pharmaceuticals IncVRTX | 9 | Strong Buy | $517.00 | +32.10% | Maintains | 2 months ago |
Biomarin Pharmaceutical IncBMRN | 4 | Strong Buy | $113.00 | +109.49% | Maintains | 2 months ago |
United Therapeutics CorpUTHR | 9 | Strong Buy | $330.00 | -17.08% | Maintains | 2 months ago |
Moderna IncMRNA | 13 | Strong Sell | $26.00 | +4.67% | Maintains | 4 months ago |
Biontech SeBNTX | 12 | Hold | $116.00 | +16.86% | Maintains | 4 months ago |
Biocryst Pharmaceuticals IncBCRX | 3 | Strong Buy | $13.00 | +67.74% | Maintains | 4 months ago |
Immunocore Holdings PLCIMCR | 5 | Strong Buy | $50.00 | +47.91% | Maintains | 5 months ago |
Novocure LtdNVCR | 4 | Hold | $28.00 | +120.82% | Maintains | 5 months ago |
Jazz Pharmaceuticals PLCJAZZ | 4 | Strong Buy | $209.00 | +65.17% | Maintains | 7 months ago |
Denali Therapeutics IncDNLI | 5 | Strong Buy | $24.00 | +81.00% | Maintains | 8 months ago |
Intra Cellular Therapies IncITCI | 6 | Strong Buy | $89.00 | -32.51% | Maintains | 10 months ago |
Mbx Biosciences IncMBX | 1 | Strong Buy | $30.00 | +207.85% | Initiates Coverage On | a year ago |
Crinetics Pharmaceuticals IncCRNX | 3 | Strong Buy | $54.00 | N/A | Maintains | a year ago |
Stoke Therapeutics IncSTOK | 2 | Hold | $13.00 | N/A | Maintains | a year ago |
Deciphera Pharmaceuticals IncDCPH | 4 | Hold | $16.00 | N/A | Maintains | a year ago |
Cerevel Therapeutics Holdings IncCERE | 4 | Hold | $45.00 | N/A | Maintains | 2 years ago |
Karuna Therapeutics IncKRTX | 1 | Hold | $330.00 | N/A | Downgrades | 2 years ago |
Rayzebio IncRYZB | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 2 years ago |
Emergent Biosolutions IncEBS | 1 | Strong Sell | $9.00 | N/A | Downgrades | 3 years ago |
Esperion Therapeutics IncESPR | 5 | Hold | $9.00 | N/A | Maintains | 3 years ago |
Seagen IncSGEN | 2 | Strong Buy | $150.00 | N/A | Maintains | 3 years ago |
Tricida IncTCDAQ | 2 | Strong Sell | N/A | N/A | Downgrades | 3 years ago |
Nektar TherapeuticsNKTR | 5 | Strong Sell | N/A | N/A | Downgrades | 3 years ago |
Amarin Corp PLCAMRN | 4 | Strong Sell | N/A | N/A | Downgrades | 3 years ago |
Tvardi Therapeutics IncTVRD | 2 | Strong Buy | $240.00 | N/A | Upgrades | 4 years ago |
Landos Biopharma IncLABP | 2 | Hold | $70.00 | N/A | Maintains | 4 years ago |
Dianthus Therapeutics IncDNTH | 1 | Hold | $7.00 | N/A | Downgrades | 4 years ago |
Lava Therapeutics NvLVTX | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | 4 years ago |
Aptinyx IncAPTX | 1 | Strong Sell | N/A | N/A | Downgrades | 5 years ago |
Lexicon Pharmaceuticals IncLXRX | 1 | Hold | $7.00 | N/A | Upgrades | 5 years ago |
Stemline Therapeutics IncSTML | 2 | Strong Buy | $8.00 | N/A | Maintains | 5 years ago |
Arena Pharmaceuticals IncARNA | 1 | Strong Buy | $58.00 | N/A | Upgrades | 6 years ago |
Axcella Health IncAXLA | 2 | Strong Buy | $275.00 | N/A | Maintains | 6 years ago |
Aprea Therapeutics IncAPRE | 1 | Hold | $460.00 | N/A | Initiates Coverage On | 6 years ago |
Mersana Therapeutics IncMRSN | 3 | Strong Sell | N/A | N/A | Downgrades | 7 years ago |
Amag Pharmaceuticals IncAMAG | 1 | Strong Sell | $18.00 | N/A | Downgrades | 7 years ago |
Radius Health IncRDUS1 | 4 | Strong Buy | $52.00 | N/A | Maintains | 7 years ago |
Chimerix IncCMRX | 1 | Strong Sell | N/A | N/A | Downgrades | 8 years ago |
Enanta Pharmaceuticals IncENTA | 1 | Hold | N/A | N/A | Downgrades | 8 years ago |
Advanced Accelerator Applications SaAAAP | 1 | Hold | N/A | N/A | Downgrades | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.